COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01347996
Brief Title: Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

First Submitted : May 2, 2011
First Submitted that Met QC Criteria : May 4, 2011
First Posted : May 5, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : November 27, 2017
Last Update Posted : November 29, 2017